Advances in CAR-T cell therapy for hematologic and solid malignancies: latest updates from 2024 ESMO Congress

Huageng Huang, Le Yu, Huawei Weng, Wei Zhang, Zhao Wang, Lin Wang, He Huang · 2024

Read Advances in CAR-T cell therapy for hematologic and solid malignancies: latest updates from 2024 ESMO Congress by Huageng Huang, Le Yu, Huawei Weng, Wei Zhang, Zhao Wang, Lin Wang, He Huang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11622581.txt.

Description

Huang and six co-authors wrote a review in twenty twenty-four on CAR-T cell therapy updates from a major cancer congress. The therapy retools a patient's T cells to hunt cancer. Blood cancers respond strongly; solid tumors show early promise. Weak cell growth, side effects, and scarce targets still limit reach. Tumor surroundings also block cell entry and sap strength. Congress reports tackle those walls from many angles. Cytokine tuning and new targets headline the strategies.

Donor-made cells, vaccine pairings, and in-body delivery appear too. Switchable activation aims to tame side effects. The review gathers the year's field directions in one place. It suits readers tracking cell therapy's frontier.

Catalog record

CREATORHuageng Huang, Le Yu, Huawei Weng, Wei Zhang, Zhao Wang, Lin Wang, He Huang
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE15 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11622581

Browse the full library · About the Tower of Babel